YNIOS Pharma (Private limited company)

BE 0783.494.239 Active ●Avenue Wolfers 32, 1310 La Hulpe

YNIOS Pharma is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0783.494.239. It was founded on 16-03-2022. Its registered office is in La Hulpe. Its main activity is: Manufacture of chemicals and chemical products. Its annual accounts for 2025 report equity of € 473 563 and a loss of € 228 903. Addrly gives it a financial health grade of C, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 18-10-2026.

Company information

Status
Active
Enterprise number
BE 0783.494.239
VAT registered
Yes
Founded
16-03-2022
Latest accounts
2025
Employees
-
Region
Wallonia
Establishments
-
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue Wolfers 32, 1310 La Hulpe
Main activity
Manufacture of chemicals and chemical products
NACE activities
20420 Fabrication de parfums et de produits pour la toilette
47750 Commerce de détail de produits cosmétiques et d'articles de toilette
72101 Recherche-développement en biotechnologie

Key figures of YNIOS Pharma

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -228 903€ 342 124€ -196 449-46 %€ -135 009
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 473 563-33 %€ 702 466+830 %€ 75 542+5 %€ 71 991
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 794 459-18 %€ 970 290+344 %€ 218 657+72 %€ 127 086
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -4 809€ 392 886€ -161 833-21 %€ -133 591
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade C, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
7 mandates on record in the annual accounts.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
FIRMENICH BELGIUM 1348 Ottignies-Louvain-la-Neuve
Société d'Etudes Techniques au Hainaut 1410 Waterloo
Floridienne 1410 Waterloo
PUGH & CO INTERNATIONAL 1435 Mont-Saint-Guibert
GROUPE K & Co. 1400 Nivelles
Vital Materials Belgium 1495 Villers-la-Ville
Savonnerie Thomas 1410 Waterloo
Chantier de Waterloo 1410 Waterloo
Looking for more information about YNIOS Pharma?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is YNIOS Pharma still active? Yes. The Crossroads Bank for Enterprises lists YNIOS Pharma as active.

What is the VAT number of YNIOS Pharma? The VAT number of YNIOS Pharma is BE 0783.494.239.

When was YNIOS Pharma founded? YNIOS Pharma was founded on 16-03-2022.

What is the address of YNIOS Pharma? The current registered office of YNIOS Pharma is Avenue Wolfers 32, 1310 La Hulpe.

When did YNIOS Pharma last file annual accounts? The latest annual accounts of YNIOS Pharma were filed on 12-06-2026.

Does YNIOS Pharma file its annual accounts on time? Yes. YNIOS Pharma filed its annual accounts within the legal deadline for each of its last 4 financial years.

Is YNIOS Pharma financially healthy? Addrly gives YNIOS Pharma a financial health grade of C, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is YNIOS Pharma profitable? The annual accounts of YNIOS Pharma for 2025 show a loss of € 228 903.

What is the equity of YNIOS Pharma? The equity of YNIOS Pharma was € 473 563 at the close of the 2025 financial year.

Who are the directors of YNIOS Pharma? The annual accounts of YNIOS Pharma record 7 mandates. The names, roles and dates are visible with a free account.

Can YNIOS Pharma receive Peppol e-invoices? Yes. YNIOS Pharma is registered on the Peppol network and can receive structured electronic invoices.

What does YNIOS Pharma do? The main activity of YNIOS Pharma is: Manufacture of chemicals and chemical products.

Sources

How Addrly builds and refreshes this data